LZ
Leslie Zacks
EVP/Chief Legal Compl. Officer

Leslie Zacks insider trades: Sciele Pharma (SCRX) stock sales

EVP/Chief Legal Compl. Officer, Sciele Pharma Last trade May 19, 2008 12 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
7
Open-market trades
since 2006
2
Companies
last trade 2008

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Leslie reports to the SEC

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 19, 2008SCRX↓ Sell10b5-1$35K
Jan 24, 2008SCRX↓ Sell10b5-1$114K
Dec 7, 2007SCRX↓ Sell10b5-1$85K
Oct 31, 2007SCRX↓ Sell10b5-1$158K
Aug 8, 2007SCRX↓ Sell10b5-1$65K
Jan 24, 2007SCRX↓ Sell$40K
Oct 31, 2006SCRX↓ Sell$136K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Leslie Zacks's insider trades

Leslie Zacks is EVP/Chief Legal Compl. Officer at Sciele Pharma (SCRX). Since Oct 31, 2006, Leslie has reported no open-market purchases and 7 sales worth $633K on SEC Form 4. There have been no open-market trades in the last 12 months.

5 sales (72% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include grants and awards (5 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SCRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.